tiprankstipranks
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF

Compare Amplia Therapeutics (INNMF) vs. Competitors

19 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Amplia Therapeutics
$0.09
$49.62M
-7.26
164.86%
Tryptamine Therapeutics
AU$55.48M
-8.64
-13.89%
Neuren Pharmaceuticals Limited
AU$12.49
AU$1.75B
58.29
-0.07%
3 Buy
0 Hold
0 Sell
Strong Buy
Paradigm Biopharmaceuticals
AU$0.33
AU$91.95M
-1.89
-45.90%
Alterity Therapeutics
AU$0.01
AU$97.88M
-6.28
-9.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zelira Therapeutics
AU$0.34
AU$5.95M
-1.60
1.01%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INNMF
Amplia Therapeutics
0.10
0.06
164.86%
AU:ENP
Tryptamine Therapeutics
0.03
>-0.01
-3.13%
AU:NEU
Neuren Pharmaceuticals Limited
13.80
-0.08
-0.58%
AU:PAR
Paradigm Biopharmaceuticals
0.17
-0.16
-48.44%
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-9.09%
AU:ZLD
Zelira Therapeutics
0.50
>-0.01
-0.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts